Get the Stockscreener App
2.20
7.84%
0.16
Pre-market:
2.19
-0.01
-0.45%
Nkarta Inc stock is traded at $2.20, with a volume of 1.04M.
It is up +7.84% in the last 24 hours and up +22.91% over the past month.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
See More
Previous Close:
$2.04
Open:
$2.02
24h Volume:
1.04M
Relative Volume:
1.33
Market Cap:
$156.26M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-0.9167
EPS:
-2.4
Net Cash Flow:
$-114.31M
1W Performance:
+6.28%
1M Performance:
+22.91%
6M Performance:
+14.58%
1Y Performance:
-9.84%
1-Day Range:
$2.01
$2.20
1-Week Range:
$1.93
$2.20
52-Week Range:
$1.31
$2.74
Nkarta Inc Stock (NKTX) Company Profile
Name
Nkarta Inc
Sector
Industry
Phone
(925) 407-1049
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Compare NKTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.20 | 144.90M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.14 | 112.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.33 | 77.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.37 | 50.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
365.46 | 46.97B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.64 | 36.99B | 4.98B | 69.59M | 525.67M | 0.5197 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-09-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-14-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-22-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| Jul-28-22 | Initiated | Needham | Buy |
| Jul-18-22 | Initiated | SVB Leerink | Outperform |
| Mar-11-22 | Initiated | Raymond James | Outperform |
| Mar-08-22 | Initiated | H.C. Wainwright | Buy |
| Jan-06-22 | Initiated | William Blair | Outperform |
| Nov-18-21 | Initiated | SMBC Nikko | Outperform |
| Jul-16-21 | Initiated | Oppenheimer | Outperform |
| Aug-04-20 | Initiated | Cowen | Outperform |
| Aug-04-20 | Initiated | Evercore ISI | Outperform |
| Aug-04-20 | Initiated | Mizuho | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Nkarta Inc Stock (NKTX) Latest News
Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Nkarta CEO Hastings sells $53,915 in NKTX stock By Investing.com - Investing.com Nigeria
Insider Selling: Nkarta (NASDAQ:NKTX) CEO Sells 26,046 Shares of Stock - MarketBeat
Insider Selling: Nkarta (NASDAQ:NKTX) President Sells 5,649 Shares of Stock - MarketBeat
Nkarta (NKTX) president Nadir sells $11,693 in shares - Investing.com
Nkarta CEO Hastings sells $53,915 in NKTX stock - Investing.com
Bearish Setup: Does Nkarta Inc have declining or rising EPSGold Moves & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Can Nkarta Inc. stock double in next 5 yearsAnalyst Upgrade & Entry Point Confirmation Alerts - bollywoodhelpline.com
Nkarta, Inc. (NASDAQ:NKTX) Short Interest Update - MarketBeat
How do insiders feel about Nkarta IncMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
Aug Update: Does Nkarta Inc align with a passive investing strategyJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
RSI Check: Will Nkarta Inc stock benefit from commodity pricesSell Signal & AI Enhanced Trading Alerts - Bộ Nội Vụ
Aug Weekly: Can Nkarta Inc stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Free Reliable Trade Execution Plans - Bộ Nội Vụ
Aug Action: Why Nkarta Inc. stock is favored by top institutionsPortfolio Risk Summary & Low Risk High Win Rate Picks - Bộ Nội Vụ
Rate Hike: Does Nkarta Inc stock trade at a discount to peersJuly 2025 Update & Expert-Curated Trade Recommendations - Bộ Nội Vụ
Is Nkarta Inc. stock affected by interest rate hikesEarnings Growth Summary & Stock Portfolio Risk Management - ulpravda.ru
Is Nkarta Inc. stock supported by strong cash flows2025 Volume Leaders & Verified Swing Trading Watchlists - ulpravda.ru
Is Nkarta Inc. stock attractive for passive investors2025 Major Catalysts & Precise Buy Zone Identification - Улправда
Fat Pitch FinancialsNkarta, Inc.Common Stock (Nasdaq:NKTX) Stock Quote - FinancialContent
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Analysts’ Recent Ratings Updates for Nkarta (NKTX) - Defense World
Nkarta Shares Show Signs of Finding a Floor - AD HOC NEWS
How strong is Nkarta Inc. stock balance sheetJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - Улправда
Why Nkarta Inc. stock is favored by top institutions2025 Volume Leaders & Daily Technical Stock Forecast Reports - Улправда
Portfolio Recap: Is Nkarta Inc. stock attractive for growth ETFsJuly 2025 Action & Fast Gain Stock Tips - Улправда
Nkarta (NASDAQ:NKTX) Rating Increased to Hold at Wall Street Zen - Defense World
Is Nkarta Inc. stock a safe buy before earningsJuly 2025 Price Swings & Weekly Stock Breakout Alerts - DonanımHaber
Nkarta, Inc.(NasdaqGS: NKTX) dropped from NASDAQ Biotechnology Index - marketscreener.com
What analysts say about Nkarta Inc stockPortfolio Diversification Tips & High Profit Trading Alerts - earlytimes.in
Nkarta, Inc. $NKTX Shares Sold by AWM Investment Company Inc. - Defense World
This trade activity should not be overlooked: Nkarta Inc (NKTX) - setenews.com
VIX Spike: Why analysts upgrade STVN stockWeekly Market Report & Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Nkarta (NASDAQ:NKTX) Downgraded by Wall Street Zen to Sell - MarketBeat
Nkarta Inc (NKTX) Performance and Fundamentals Dashboard tells a completely different story - setenews.com
We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully - Yahoo Finance
Why Nkarta Inc. stock remains undervaluedBond Market & Weekly Return Optimization Alerts - Newser
Nkarta to Participate in Evercore Healthcare Conference - The Manila Times
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Nkarta (NASDAQ:NKTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
It is Poised to be a Bull Market for Nkarta Inc (NKTX) - setenews.com
Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
How interest rate cuts could boost Nkarta Inc. stockMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
Why Nkarta Inc. stock appeals to dividend seekers2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Using Python tools to backtest Nkarta Inc. strategiesWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Will Nkarta Inc. stock split again soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
How Nkarta Inc. stock benefits from strong dollarOil Prices & Reliable Trade Execution Plans - newser.com
A better buy-in window may exist right now for Nkarta Inc (NKTX) - setenews.com
Nkarta Inc Stock (NKTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.17%
4.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):